Inventor · disambiguated record
David A. Eavarone
Also filed as: EAVARONE DAVID · EAVARONE DAVID A
3 granted patents·32 pending applications·3 citations·filing 2005–2023
56Inventor score
Files withSEAGEN INC15MASSACHUSETTS INST TECHNOLOGY10SENGUPTA SHILADITYA4SEATTLE GENETICS INC3SIAMAB THERAPEUTICS INC2
Top patents by PatentIndex Score
35 records- 0183US11028181B2Glycan-interacting compounds and methods of useSEAGEN INC·Filed 2016·Granted Jun 8, 2021·3 cites·93 claims
- 0276US2024343826A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2023·Application pending·0 cites
- 0375US2024343834A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2023·Application pending·0 cites
- 0473US2023331868A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2023·Application pending·0 cites
- 0571US2024003889A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2022·Application pending·0 cites
- 0671US2024002537A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2022·Application pending·0 cites
- 0769US2024000962A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2022·Application pending·0 cites
- 0868US2023312747A1Compositions and Methods for Treating CancerSEAGEN INC·Filed 2022·Application pending·0 cites
- 0967US2022259323A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2021·Application pending·0 cites
- 1066US2023022411A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2022·Application pending·0 cites
- 1165US2022057402A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2021·Application pending·0 cites
- 1265US2023001007A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2022·Application pending·0 cites
- 1365US2023142697A1Glycan-Interacting Compounds and Methods of UseSEAGEN INC·Filed 2022·Application pending·0 cites
- 1465US2023029085A1Compositions and Methods for Targeting Cancer Stem CellsSEAGEN INC·Filed 2022·Application pending·0 cites
- 1560US2021011021A1Glycan-Interacting Compounds and Methods of UseSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 1658US11253609B2Glycan-interacting compounds and methods of useSEAGEN INC·Filed 2018·Granted Feb 22, 2022·0 cites·13 claims
- 1758US2014363497A1Nanocell Drug Delivery SystemMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Application pending·0 cites
- 1857US11401330B2Glycan-interacting compounds and methods of useSEATTLE GENETICS INC·Filed 2017·Granted Aug 2, 2022·0 cites·10 claims
- 1957US2015099001A1Nanocell Drug Delivery SystemMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Application pending·0 cites
- 2056US2013216474A1Nanocells for diagnosis and treatment of diseases and disordersMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
- 2155US2013177607A1Nanocell Drug Delivery SystemMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
- 2255US2013171205A1Nanocell Drug Delivery SystemMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
- 2353US2013171091A1Nanocell Drug Delivery SystemMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
- 2452US2020247902A1Compositions and methods for treating cancerSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 2552US2019031780A1Compositions and methods for targeting cancer stem cellsSIAMAB THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2651US2009110633A1Nanocells for Diagnosis and Treatment of Diseases and DisordersSENGUPTA SHILADITYA·Filed 2006·Application pending·0 cites
- 2749US2020041517A1Compositions and methods for targeting cancer stem cellsSIEATTLE GENETICS INC·Filed 2016·Application pending·0 cites
- 2849US2010303912A1Nanocell Drug Delivery SystemMASSACHUSETTS INST TECHNOLOGY·Filed 2010·Application pending·0 cites
- 2949US2007020243A1Methods and compositions related to modulating the extracellular stem cell environmentMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Application pending·0 cites
- 3048US2007053845A1Nanocell drug delivery systemSENGUPTA SHILADITYA·Filed 2006·Application pending·0 cites
- 3147US2011280799A1Nanocells for diagnosis and treatment of diseases and disordersSENGUPTA SHILADITYA·Filed 2011·Application pending·0 cites
- 3247US2010272822A1Nanocell drug delivery systemMASSACHUSETTS INST TECHNOLOGY·Filed 2010·Application pending·0 cites
- 3346US2005266067A1Nanocell drug delivery systemSENGUPTA SHILADITYA·Filed 2005·Application pending·0 cites
- 3442US2017306046A1Glycan-interacting compounds and methods of useSIAMAB THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3540US2010119494A1Methods and compositions related to modulating the extracellular stem cell environmentMASSACHUSETTS INST TECHNOLOGY·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →